Back to announcement
20241213_BMHS_Laporan Informasi dan Fakta Material_31819040_lamp1.pdf
Other Text extracted BMHSSource file signed link, expires in 15 minutes
Extracted text 2
Page 1 OCR 0.921
@ bmhs
since 1973
Jakarta, 13 Desember 2024/ December 13", 2024
No. : 530-K/PD/BMHS/XII/2024
Lampiran/Att. : -
Perihal/ Re. : Keterbukaan Informasi Hasil Pelaksanaan MESOP PT Bundamedik Tbk (“Perseroan”)/
Disclosure of Information on the Results of MESOP Implementation of PT Bundamedik
Tbk (the “Company”)
Kepada Yth./To:
Otoritas Jasa Keuangan ("OJK")
Gedung Sumitro Djojohadikusumo
Jl. Lapangan Banteng Timur No. 2-4
Jakarta Pusat - 10710
U.p./Attn.To : Yth. Bapak I Gede Nyoman Yetna
Direktur Penilaian Perusahaan
Director of Corporate Assessment
Dengan hormat,
Merujuk kepada Surat Perseroan Nomor 439-
K/PD/BMHS/X/2024 tanggal 25 Oktober 2024
perihal Keterbukaan Informasi Periode
Pelaksanaan MESOP. Maka sehubungan dengan
periode pelaksanaan Management and Employee
Stock Option Program (“MESOP”) pada tanggal
01 November 2024 sampai dengan tanggal 12
Desember 2024, dan sesuai dengan ketentuan
yang diatur dalam Surat Edaran BEI Nomor SE-
00002/BEI/03-2020, maka dengan ini Perseroan
menyampaikan keterbukaan informasi terkait
Yours faithfully,
Referring to the Company Letter 439-
K/PD/BMHS/X/2024 dated October 25", 2024
regarding Disclosure of Information on the
MESOP Implementation Period. Then in
accordance to the implementation period of the
Management and Employee Stock Option
Program (“MESOP”) November 15, 2024 to
December 12", 2024, and according to the
provisions stipulated in IDX Circular Letter
Number SE-00002/BEI/03-2020, the Company
hereby submit information disclosure related to
dengan hasil pelaksanaan MESOP sebagai the results of MESOP Implementation are as
berikut: follows:
No. Keterangan/Description Penjelasan/Explanation
1. Jumlah opsi yang telah dilaksanakan hak | Onihil/ none
konversinya dan jumlah saham baru yang telah
diterbitkan untuk periode pelaksanaan Tahap |
Window Exercise II/ The Number of options with
conversion rights that have been exercised and
number of new shares issued for the period of
Phase I Window Exercise II.
sa
PT Bundamedik Tbk
Jl. Teuku Cik Ditiro No. 28, Menteng, Jakarta 10350, Indonesia
Head Office: HDI Hive Menteng, 6”-7" Floor, Jl. Probolinggo No. 18, Menteng, Jakarta 10350, Indonesia
(462 2150980799 & www.bmhs.co.id
Embryo Throughout L
Page 2 OCR 0.932
since 1973 @ bmhs 2. Jumlah opsi yang telah dilaksanakan hak | O nihil/ none konversinya dan jumlah saham baru yang telah diterbitkan untuk periode pelaksanaan Tahap II Window Exercise I/ The Number of options with conversion rights that have been exercised and number of new shares issued for the period of Phase II Window Exercise I. 3, Jumlah opsi yang belum dilaksanakan dan masih | 22.500.000 saham/ shares berlaku untuk periode pelaksanaan Tahap | Window Exercise II / The number of options that have not been exercised and are still valid for the period of Phase I Window Exercise II. 4. Jumlah opsi yang belum dilaksanakan dan masih | 2.500.000 saham/ shares berlaku untuk periode pelaksanaan Tahap II Window Exercise | / The number of options that have not been exercised and are still valid for the period of Phase II Window Exercise I. 5s Jumlah saham MESOP yang belum dilaksanakan | O nihil/ none dan habis masa berlakunya untuk periode pelaksanaan Tahap | Window Exercise II / The number of MESOP shares that have not been exercised and expired for the period of Phase I Window Exercise II. 6. Jumlah saham MESOP yang belum dilaksanakan | O nihil/ none dan habis masa berlakunya untuk periode pelaksanaan Tahap II Window Exercise I/ The number of MESOP shares that have not been exercised and expired for the period of Phase II Window Exercise I. Demikian keterbukaan informasi ini kami Hereby we convey this disclosure of information. sampaikan. Atas perhatian dan kerjasamanya, Thank you for your attention and cooperation. kami ucapkan terima kasih. Hormat kami/Regards, PT Bundamedik Tbk Agus Heru Darjono 3 president Director PT Bundamedik Tbk Jl Teuku Cik Ditiro No. 28, Menteng, Jakarta 10350, Indonesia Head Office: HDI Hive Menteng, 6"-7" Floor, Jl. Probolinggo No. 18, Menteng, Jakarta 10350, Indonesia (162 2150980799 & www.bmhs.co.id From Embryo Throughout Life
Names mentioned 4 people and organisations named in the text · linked when the evidence is strong
unresolved
person
I Gede Nyoman Yetna
p.1
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.